Meditation and neurodegenerative diseases

Newberg, Andrew; Serruya, Mijail; Wintering, Nancy; Moss, Aleeze; Reibel, Diane K.; Monti, Daniel

doi:10.1111/nyas.12187

Cited by 53 publications

(30 citation statements)

References 72 publications

(138 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…La aplicación de Mindfulness en el tratamiento adyuvante para pacientes con demencias, ha sido objeto de importantes investigaciones que apoyan la aplicación de estas técnicas de meditación para ayudar a mejorar la cognición y la memoria en pacientes con enfermedades neurodegenerativas ( Newberg et al, 2014).…”

Section: Producción Cientificaunclassified

Mindfulness Y Rehabilitación Neurocognitiva

Iglesias¹,

Barrio²,

González‐Santos³

et al. 2017

Revista INFAD de Psicología

View full text Add to dashboard Cite

Abstract.MINDFULNESS AND NEUROCOGNITIVE REHABILITATION.Nowadays approximately fifty million persons are suffering from dementia throughout the world according to the latest statistics of the European Commission (2016). Moreover, every year new 7.7 million instances of this disease are detected. At this moment, Alzheimer’s disease would be the most common mental disorder in terms of world population health, in other words, this disease can signify 70% of all dementia. Even now pharmacological treatments are ineffective. Consequently, utilization of non pharmacological therapies is opening a wide range of possibilities aimed to increase prevention and, at the same time, improvement in living standards of careers and relatives of patients with dementia who are usually overburdened. This presentation contains a review about researches on mindfulness (MF) and its implementation like potentially strategies aimed to treat this disorder.Keywords: Dementias, Mindfulness, Neuroimagen, meta-analysis.Resumen.Los últimos datos aportados por la Comisión Europea señalan que la demencia afecta actualmente a casi cincuenta millones de personas en todo el mundo y que cada año se detectan 7.7 millones de nuevos casos. A día de hoy, el Alzheimer es la demencia más padecida por la población mundial pudiendo constituir en términos relativos el 70% de las demencias. En la actualidad no existen tratamientos farmacológicos que den una respuesta definitiva a este tipo de patologías. Las utilizaciones de terapias no farmacológicas abren un amplio abanico de posibilidades desde el ámbito de la prevención, y de la mejora de la calidad de vida en cuidadores y familiares de enfermos con demencia, básicamente con sintomatología de “sobrecarga”. En este articulo hacemos una revisión sobre investigaciones relacionadas con la “atención plena” ( MF) y de su implementación como estrategias potenciales en el abordaje de este tipo de patologías. Los últimos trabajos aportados con técnicas morfométricas por neuroimagen constituyen un importante avance a la hora de intentar aportar evidencia científica en este campo.Palabras clave: Demencias, Mindfulness, Neuroimagen, Meta-análisis, Rehabilitación.

show abstract

Section: Producción Cientificaunclassified

Mindfulness Y Rehabilitación Neurocognitiva

Iglesias¹,

Barrio²,

González‐Santos³

et al. 2017

Revista INFAD de Psicología

View full text Add to dashboard Cite

show abstract

“…Study heterogeneity could explain the mixed results of either type of meditation on attention enhancement. Whilst positive studies have demonstrated varying improvement across all of the attentional domains, the effect on alerting attention appears particularly strong [105]. Meditation shows promise as a cost effective, safe attentional enhancer but randomised controlled trials with standardised paradigms systematically assessing short and long term effects are required before firm conclusions can be drawn.…”

Section: Enhancing Attention Using Diet and Lifestylementioning

confidence: 99%

Enhancing attention in neurodegenerative diseases: current therapies and future directions

Sharma

Coulthard

2016

Translational Neuroscience

View full text Add to dashboard Cite

We all experience at least occasional lapses in attention but in some neurological conditions, loss of attention is pervasive and debilitating. Treating deficits in attention first requires an understanding of the neurobiology of attention, which we now understand to be a set of different cognitive processes. Cholinesterase inhibitors are already established as effective attentional enhancers used in the treatment of certain dementias. Other stimulant agents such as modafanil, amphetamine and methylphenidate have demonstrated limited success in healthy individuals where attention is already optimal and clinical trials in patients with neurological disease are sparse. Dietary and lifestyle changes are gaining increasing prominence, as are experimental treatments such as deep brain stimulation and transcranial magnetic stimulation. As the therapeutic arsenal widens, clinicians will be able to match specific treatments to selective deficits in attention, giving patients a tailored management plan. Here we review common diseases that impair attention and emphasise how an understanding of attentional processing within the brain might lead to improved therapeutic strategies.

show abstract

“…Not only are these techniques easily accessible and low in cost, but also there have been growing research findings to suggest a role in strengthening coping skills and improving cognition, memory, and attention in general. 18 Patients with PD also commonly report that meditation has helped motor symptoms, especially tremor, as well as mood, anxiety, and quality of life. To date, however, formal assessments of potential benefits have not been published.…”

Section: Mindfulnessmentioning

confidence: 99%

Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits

Rabin

Stevens-Haas

Havrilla

et al. 2015

Movement Disord Clin Pract

View full text Add to dashboard Cite

Background: Nearly half of all patients with Parkinson's disease (PD) utilize some form of complementary therapy often identified on the Internet and frequently not reported to their physicians. Treating physicians are sometimes unaware of such treatments, including their rationale, mechanisms, potential efficacy, and potential adverse effects. Methods: Methods for this study included systematic Internet search of products recommended for PD, medical literature review to determine scientific rationale, any evidence of efficacy, and potential risks.

show abstract

Meditation and neurodegenerative diseases

Cited by 53 publications

References 72 publications

Mindfulness Y Rehabilitación Neurocognitiva

Mindfulness Y Rehabilitación Neurocognitiva

Enhancing attention in neurodegenerative diseases: current therapies and future directions

Complementary Therapies for Parkinson's Disease: What's Promoted, Rationale, Potential Risks and Benefits

Contact Info

Product

Resources

About